Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Neural Regulation01:37

Neural Regulation

42.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scn4b Modulates Huntington's Disease Phenotype Severity in vivo.

bioRxiv : the preprint server for biology·2026
Same author

Optineurin is a gatekeeper of mitochondrial health and proteostasis in Alzheimer's disease vulnerable neurons.

bioRxiv : the preprint server for biology·2026
Same author

Artificial intelligence-driven whole-brain cell mapping with highly multiplexed in situ hybridization.

Neuron·2026
Same author

Divergent mitochondrial and metabolic adaptations shape selective vulnerability in ALS.

bioRxiv : the preprint server for biology·2026
Same author

Translational reprogramming of dentate gyrus peptidergic circuitry gates antidepressant efficacy.

Molecular psychiatry·2026
Same author

Identification of a thermogenic target in the dorsal raphe nucleus for weight management in mice.

Nature communications·2026

Related Experiment Video

Updated: Dec 16, 2025

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.4K

Selective Neuronal Vulnerability in Alzheimer's Disease: A Network-Based Analysis.

Jean-Pierre Roussarie1, Vicky Yao2, Patricia Rodriguez-Rodriguez3

  • 1Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065, USA.

Neuron
|July 1, 2020
PubMed
Summary

Researchers identified key molecular mechanisms driving neuron vulnerability in Alzheimer's disease (AD). This study reveals conserved cellular pathways in mice and humans, offering new targets for AD treatment.

Keywords:
Alzheimer's diseasePTBP1bacTRAPmachine learningnetworkselective neuronal vulnerability

More Related Videos

Viability Assays for Cells in Culture
12:03

Viability Assays for Cells in Culture

Published on: January 20, 2014

47.1K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K

Related Experiment Videos

Last Updated: Dec 16, 2025

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.4K
Viability Assays for Cells in Culture
12:03

Viability Assays for Cells in Culture

Published on: January 20, 2014

47.1K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K

Area of Science:

  • Neuroscience
  • Genomics
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) is characterized by selective neuronal vulnerability, yet the underlying molecular mechanisms remain poorly understood.
  • Understanding these mechanisms is crucial for developing effective AD treatments.

Purpose of the Study:

  • To develop a molecular framework for understanding selective neuronal vulnerability in Alzheimer's disease.
  • To identify conserved molecular pathways and gene modules associated with AD neuropathology in vulnerable neurons.

Main Methods:

  • Integrated neuron-type-specific molecular profiles from healthy mice (using bacTRAP) with human functional genomics and quantitative genetics data.
  • Analyzed cross-species data to identify conserved cellular taxonomy and molecular signatures.
  • Utilized functional genomics to pinpoint specific gene modules linked to neurodegeneration.

Main Results:

  • Demonstrated human-mouse conservation of molecular taxonomy for AD-vulnerable and resistant neurons.
  • Identified specific genes and pathways implicated in AD neuropathology.
  • Pinpointed a functional gene module associated with axonal remodeling, affected by amyloid accumulation and aging, underlying selective vulnerability.

Conclusions:

  • The study provides a comprehensive molecular framework for understanding the interplay of amyloid-beta, aging, and neurodegeneration in vulnerable neurons.
  • Identified conserved molecular targets for potential therapeutic interventions in Alzheimer's disease.
  • Cell-type-specific molecular profiles and functional networks are publicly available for further research.